RPX publishes reports on trends and activities in the NPE patent litigation space. Please see below for our latest.
Our RPX Q2 2015 Public PAE Report, the latest edition of our quarterly update on publicly traded patent assertion entities, shows that public PAE stocks continue to underperform the market, declining in the aggregate by 2.3% versus a NASDAQ gain of 2.2% during the quarter.
Read moreThe relatively recent proliferation of publicly traded patent assertion entities (PAEs) has cast some light on the ways in which PAEs seek to earn revenue based on their primary factors of production—capital and patents. Our RPX Q1 2015 Public PAE Report provides summary statistics for a variety of metrics relevant to the public market.
Read moreNPEs cost operating companies an estimated $12.2 billion in 2014. Our RPX 2014 NPE Cost Report – High-level Findings summarizes the costs of NPE activity to operating companies, and is intended to help quantify for litigators, heads of IP, GCs, CFOs, and CEOs the decisions companies are making about their NPE risk.
Read more